The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulationVITETTA, E. S; UHR, J. W.Transplantation. 1984, Vol 37, Num 6, pp 535-538, issn 0041-1337Article

Cellular processing of a ricin-antibody conjugate: a kinetic analysis of the rate-limiting stepMARSH, J. W.The Journal of biological chemistry (Print). 1989, Vol 264, Num 18, pp 10405-10410, issn 0021-9258, 6 p.Article

Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins = Elimination de cellules leucémiques-T clonogènes de la moelle osseuse humaine à l'aide d'immunotoxines antiprotéines de masse moléculaire 65000STONG, R. C; YOULE, R. J; VALLERA, D. A et al.Cancer research (Baltimore). 1984, Vol 44, Num 7, pp 3000-3006, issn 0008-5472Article

Therapeutic targets and recent advances in protein immunotoxinsMADHUMATHI, J; VERMA, Rama S.Current opinion in microbiology. 2012, Vol 15, Num 3, pp 300-309, issn 1369-5274, 10 p.Article

Mab-zap : A tool for evaluating antibody efficacy for use in an immunotoxinKOHLS, M. D; LAPPI, D. A.BioTechniques. 2000, Vol 28, Num 1, pp 162-165, issn 0736-6205Article

Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patientsDURRANT, L. G; BYERS, V. S; SCANNON, P. J et al.Clinical and experimental immunology (Print). 1989, Vol 75, Num 2, pp 258-264, issn 0009-9104Article

Immunotoxins : will their clinical promise be fulfilled ?VALLERA, D. A.Blood. 1994, Vol 83, Num 2, pp 309-317, issn 0006-4971Article

Immune therapies for malignant mesotheliomaANTONIU, Sabina Antonela; DIMOFTE, Gabriel; UNGUREANU, Didona et al.Expert review of anticancer therapy. 2014, Vol 14, Num 8, pp 965-973, issn 1473-7140, 9 p.Article

Cytotoxic Activity of Immunotoxin SS1 P Is Modulated by TACE-Dependent Mesothelin SheddingYUJIAN ZHANG; CHERTOV, Oleg; JINGLI ZHANG et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5915-5922, issn 0008-5472, 8 p.Article

Antibody toxin conjugates: a perspectiveBLAKEY, D. C; WAWRZYNCZAK, E. J; WALLACE, P. M et al.Progress in allergy. 1988, Vol 45, pp 50-90, issn 0079-6034Article

Novel photocleavable protein crosslinking reagents and their use in the preparation of antibody-toxin conjugatesSENTER, P. D; TANSEY, M. J; LAMBERT, J. M et al.Photochemistry and photobiology. 1985, Vol 42, Num 3, pp 231-237, issn 0031-8655Article

Attempts to Express the A1-GMCSF Immunotoxin in the Baculovirus Expression Vector SystemJAHANIAN-NAJAFABADI, Ali; BOUZARI, Saeid; OLOOMI, Mana et al.Bioscience, biotechnology, and biochemistry. 2012, Vol 76, Num 4, pp 749-754, issn 0916-8451, 6 p.Article

Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment- targeted melittinXIAORONG ZHAO; ZHEN YU; LIMIN CAO et al.Biotechnology and applied biochemistry. 2011, Vol 58, pp 405-411, issn 0885-4513, 7 p., 6Article

An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensinHERTLER, A. A; SCHLOSSMAN, D. M; BOROWITZ, M. J et al.International journal of cancer. 1989, Vol 43, Num 2, pp 215-219, issn 0020-7136Article

Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancerWELTMAN, J. K; PEDROSO, P; JOHNSON, S.-A et al.Cancer research (Baltimore). 1987, Vol 47, Num 21, pp 5552-5556, issn 0008-5472Article

Determination of sensitivity of fresh leukemia cells to immunotoxinsLAURENT, G; KUHLEIN, E; CASELLAS, P et al.Cancer research (Baltimore). 1986, Vol 46, Num 5, pp 2289-2294, issn 0008-5472Article

Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxinSIENA, S; VILLA, S; BREGNI, M et al.Blood. 1987, Vol 69, Num 1, pp 345-348, issn 0006-4971Article

Immunotoxin therapy of lymphoid neoplasmsGROSSBARD, M. L; NADLER, L. M.Seminars in hematology. 1994, Vol 31, Num 1, pp 88-97, issn 0037-1963Article

Immunotoxins to human small-cell lung cancerWAWRZYNCZAK, E. J; DERBYSHIRE, E. J.Cell biophysics. 1992, Vol 21, Num 1-3, pp 13-23, issn 0163-4992Conference Paper

Specific immunosuppression by immunotoxins containing daunomycinDIENER, E; DINER, U. E; SINHA, A et al.Science (Washington, D.C.). 1986, Vol 231, Num 4734, pp 148-150, issn 0036-8075Article

Purification of ricin A₁, A₂, and B chains and characterization of their toxicityFULTON, R. J; BLAKEY, D. C; KNOWLES, P. P et al.The Journal of biological chemistry (Print). 1986, Vol 261, Num 12, pp 5314-5319, issn 0021-9258Article

Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from bloodRAMAKRISHNAN, S; HOUSTON, L. L.Cancer research (Baltimore). 1985, Vol 45, Num 5, pp 2031-2036, issn 0008-5472Article

HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicityBANG, Sookhee; NAGATA, Satoshi; ONDA, Masanori et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1545-1550, issn 1078-0432, 6 p.Article

Recombinant immunotoxins for the treatment of cancerFITZGERALD, D; PASTAN, I.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 261-266, issn 0168-3659, 5 p.Conference Paper

Monensin enhances the cytotoxic effect of antitransferrin receptor immunotoxin on cultured RPE cellsHANDA, J. T; HOUSTON, L. L; JAFFE, G. J et al.Current eye research (Print). 1993, Vol 12, Num 1, pp 45-53, issn 0271-3683Article